Additional file 3 of Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women

Authors :: Bartlett, Thomas E.
Evans, Iona
Jones, Allison
Barrett, James E.
Haran, Shaun
Reisel, Daniel
Papaikonomou, Kiriaki
Jones, Louise
Herzog, Chiara
Pashayan, Nora
Simões, Bruno M.
Clarke, Robert B.
Evans, D. Gareth
Ghezelayagh, Talayeh S.
Ponandai-Srinivasan, Sakthivignesh
Boggavarapu, Nageswara R.
Lalitkumar, Parameswaran G.
Howell, Sacha J.
Risques, Rosa Ana
Rådestad, Angelique Flöter
Dubeau, Louis
Gemzell-Danielsson, Kristina
Widschwendter, Martin
Publication Year :: 2022
Publisher :: figshare, 2022.
Abstract: Additional file 3. Is the protocol for Clinical Trial 2, ‘The effect of a progesterone receptor modulator on breast tissue in women with BRCA1 and 2 mutations’ (EudraCT registration number: 2012-003703-35).

Full Text Access

Tools